Login
$DCTH
$19.87 -$0.68 (3.31%) Live

$DCTH SEC Filings

Filed On Filing
13 Nov 2026 Form 4
12 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 10-Q
09 Nov 2026 8-K: Results of Operations and Financial Condition

Increases 2026 Revenue Guidance to a Range of $115 million to $117 million

27 Oct 2026 SCHEDULE 13G
19 Oct 2026 SCHEDULE 13D/A
14 Oct 2026 Form 4: Rosalind Advisors, Inc., Director and 2 others

Received 3,627 shares by conversion · Disposed of 27,502 shares (Other Transaction)

14 Aug 2026 S-8
14 Aug 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

Section 1.1 Registered Office. The registered office of Delcath Systems, Inc. (the “Corporation”) in the State of Delaware and the name of the Corporation’s registered agent at such address shall be as set forth in the certificate of inc...

06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Increases 2026 Revenue Guidance to a Range of $104M to $108M

28 Jul 2026 SCHEDULE 13G
14 May 2026 Form 4: Sylvester John Richard, Director

Granted 22,500 Stock Option (right to buy)

14 May 2026 Form 4: Martell Bridget A, Director

Granted 22,500 Stock Option (right to buy)

14 May 2026 Form 4: Czerepak Elizabeth, Director

Granted 22,500 Stock Option (right to buy)

14 May 2026 Form 4: Salamon Steven A J, Director

Granted 22,500 Stock Option (right to buy)

14 May 2026 Form 4: Aharon Gil, Director

Granted 22,500 Stock Option (right to buy)

14 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

(As adopted by Board of Directors on September 30, 2020 and approved by stockholders on November 23, 2020)

07 May 2026 10-Q
07 May 2026 8-K: Results of Operations and Financial Condition

QUEENSBURY, NY – May 7, 2026, Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the fi...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support